Injective is entering a strategic collaboration with KardiaChain to expand the cross-chain trading universe.

KardiaChain is a blockchain platform that aims to be fully interoperable and “non-invasive,” meaning that blockchains can connect to the network without needing to make technical modifications to their own protocols. KardiaChain uses a dual-node structure to facilitate the connection between its own ledger and other blockchains. The platform has been working with the likes of the Enterprise Ethereum Alliance, Theta, NEO, Ontology, LD, and Injective collaborator Polygon.

The goal is to add KardiaChain to Injective in order to provide more assets for users to trade. This encompasses new derivative products that include the KardiaChain token.

The native Injective Chain was created to support both interoperability and scalability. In this effort Injective has begun to integrate with leading layer one protocols such as Polkadot, BSC, and Avalanche.

Moving forward, KardiaChain can utilize Injective’s innovative layer-2 solution to meet high scalability demands within the DeFi ecosystem and enterprise solutions that require a scalable network. Some examples of these DApps can include KardiaChain’s new mobile payment gateway in collaboration with Vietnam’s largest telco that currently has millions of users.

About KardiaChain

KardiaChain is a blockchain platform that aims to be fully interoperable and “non-invasive,” meaning that blockchains can connect to the network without needing to make technical modifications to their own protocols. KardiaChain uses a dual-node structure to facilitate the connection between its own ledger and other blockchains, sharding for scalability and smart contracts for developers.

About Injective

Injective is the first cross-chain protocol built for decentralized finance applications. On the Injective exchange, anyone can access, create, and trade unlimited DeFi markets such as futures and perpetuals. Developers can also build cross-chain Ethereum-compatible projects that are lightning fast and achieve instant transaction finality. Injective is backed by a prominent group of stakeholders including Binance, Pantera Capital and Mark Cuban.

Website | Telegram | Discord | Blog | Twitter | Learn | Youtube | Facebook | LinkedIn | Reddit | Instagram | Weibo | Orbit Newsletter